Abionyx Pharma (France) Today
| ABNX Stock | EUR 1.09 0.02 1.80% |
Performance0 of 100
| Odds Of DistressLess than 28
|
Abionyx Pharma is trading at 1.09 as of the 17th of April 2024, a -1.8 percent decrease since the beginning of the trading day. The stock's open price was 1.11. Abionyx Pharma has about a 28 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Abionyx Pharma SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of July 2023 and ending today, the 17th of April 2024. Click here to learn more.
ABIONYX Pharma SA, a biopharmaceutical company, discovers and develops high density lipoprotein therapies for the treatment of cardiovascular and metabolic diseases. ABIONYX Pharma SA was founded in 2005 and is based in Labege, France. ABIONYX PHARMA is traded on Paris Stock Exchange in France.. The company has 28.09 M outstanding shares. More on Abionyx Pharma SA
Moving together with Abionyx Stock
| 0.78 | DBV | DBV Technologies | PairCorr |
| 0.79 | IPH | Innate Pharma | PairCorr |
Moving against Abionyx Stock
| 0.9 | CS | AXA SA | PairCorr |
| 0.85 | MEDCL | Medincell SA | PairCorr |
| 0.77 | VRLA | Verallia Earnings Call Next Week | PairCorr |
| 0.73 | MC | LVMH Mot Hennessy | PairCorr |
| 0.73 | GNE | General Electric Earnings Call This Week | PairCorr |
| 0.7 | ABVX | Abivax SA | PairCorr |
| 0.66 | CDI | Christian Dior SE Earnings Call This Week | PairCorr |
Abionyx Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Abionyx Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Abionyx Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Cyrille Tupin |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Abionyx Pharma SA (ABNX) is traded on Euronext Paris in France and employs 62 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 52.53 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abionyx Pharma's market, we take the total number of its shares issued and multiply it by Abionyx Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Abionyx Pharma SA operates under Healthcare sector and is part of Biotechnology industry. The entity has 28.09 M outstanding shares.
Abionyx Pharma SA has accumulated about 8.33 M in cash with (6.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38.
Check Abionyx Pharma Probability Of Bankruptcy
Ownership AllocationAbionyx Pharma SA retains a total of 28.09 Million outstanding shares. Abionyx Pharma SA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Abionyx Ownership Details
Abionyx Stock Price Odds Analysis
What are Abionyx Pharma's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Abionyx Pharma jumping above the current price in 90 days from now is about 60.75%. The Abionyx Pharma SA probability density function shows the probability of Abionyx Pharma stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Abionyx Pharma SA has a beta of -0.2886. This suggests as returns on the benchmark increase, returns on holding Abionyx Pharma are expected to decrease at a much lower rate. During a bear market, however, Abionyx Pharma SA is likely to outperform the market. Additionally, abionyx Pharma SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Abionyx Pharma to move above the current price in 90 days from now is about 60.75 (This Abionyx Pharma SA probability density function shows the probability of Abionyx Stock to fall within a particular range of prices over 90 days) .
Abionyx Pharma SA Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Abionyx Pharma market risk premium is the additional return an investor will receive from holding Abionyx Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Abionyx Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Abionyx Pharma's alpha and beta are two of the key measurements used to evaluate Abionyx Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.73 | |||
| Standard Deviation | 2.58 | |||
| Variance | 6.63 | |||
| Risk Adjusted Performance | (0.04) |
Abionyx Stock Against Markets
Picking the right benchmark for Abionyx Pharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Abionyx Pharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Abionyx Pharma is critical whether you are bullish or bearish towards Abionyx Pharma SA at a given time. Please also check how Abionyx Pharma's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Abionyx Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Abionyx Pharma Corporate Management
Elected by the shareholders, the Abionyx Pharma's board of directors comprises two types of representatives: Abionyx Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Abionyx. The board's role is to monitor Abionyx Pharma's management team and ensure that shareholders' interests are well served. Abionyx Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Abionyx Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gavin Sy | Director of Production | Profile | |
| Emmanuel Huynh | Chairman of the Board | Profile | |
| Ronald Barbaras | Director of Exploratory Biology | Profile | |
| Barbara Yanni | Independent Director | Profile | |
| Constance Keyserling | Director of Clinical Development and Operations | Profile | |
| Denis Lucquin | Director - Representative of Sofinnova | Profile | |
| Renee Benghozi | Director of Clinical Research | Profile |
How to buy Abionyx Stock?
Before investing in Abionyx Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Abionyx Pharma. To buy Abionyx Pharma stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Abionyx Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Abionyx Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Abionyx Pharma SA stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Abionyx Pharma SA stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Abionyx Pharma SA, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Abionyx Pharma SA?
The danger of trading Abionyx Pharma SA is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Abionyx Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Abionyx Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Abionyx Pharma SA is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abionyx Pharma SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Abionyx Stock analysis
When running Abionyx Pharma's price analysis, check to measure Abionyx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abionyx Pharma is operating at the current time. Most of Abionyx Pharma's value examination focuses on studying past and present price action to predict the probability of Abionyx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abionyx Pharma's price. Additionally, you may evaluate how the addition of Abionyx Pharma to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |